No Picture

Atara Biotherapeutics Presents Initial ATA188 Phase 1 Safety Results for Patients with Progressive Multiple Sclerosis at the 5th Congress of the European Academy of Neurology (EAN)

SOUTH SAN FRANCISCO, Calif., June 29, 2019 (GLOBE NEWSWIRE) — Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral dis… […]

No Picture
San Francisco Biotech Jobs

Recruiter – BioMarin – Novato, CA

5+ years of biotech, pharmaceutical or healthcare sourcing, recruiting/search experience with a variety of levels….From BioMarin – Sat, 29 Jun 2019 06:17:05 GMT – View all Novato, CA jobs […]